Citation Impact
Citing Papers
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
2008 Standout
Microalbuminuria as predictor of increased mortality in elderly people.
1990
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Cardiovascular disease risk factors as predictors of Type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects
1993
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
1992
Diabetes and Decline in Heart Disease Mortality in US Adults
1999
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Development of the Multiple Metabolic Syndrome: An Epidemiologic Perspective
1998
Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial
1993 Standout
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
1997 StandoutNature
Differential Effects of Lipid-Lowering Therapies on Stroke Prevention
2003
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
A Role for Ceramide, but Not Diacylglycerol, in the Antagonism of Insulin Signal Transduction by Saturated Fatty Acids
2003
The metabolic syndrome
2010 Standout
Saturated Fatty Acid and TLR Signaling Link β Cell Dysfunction and Islet Inflammation
2012
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Cardiovascular risk continuum: implications of insulin resistance and diabetes
1998
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
1998 Standout
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Insulin as a predictor of coronary heart disease: Interaction with apolipoprotein E phenotype A report from the multiple risk factor intervention trial
1994
The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study
2004
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Serum Insulin and Incident Coronary Heart Disease in Middle-aged British Men
1996
THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE
1989
Hyperinsulinaemia is not a major coronary risk factor in elderly men
1992
Diabetes epidemiology as a tool to trigger diabetes research and care
1999
Combined oral contraceptives in the treatment of polycystic ovary syndrome
2005
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)
2007
Polycystic Ovary Syndrome
1995 Standout
Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men
2004
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Effects of Varying Carbohydrate Content of Diet in Patients With Non—Insulin-Dependent Diabetes Mellitus
1994
Global and societal implications of the diabetes epidemic
2001 StandoutNature
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction
2002
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Is visceral obesity the cause of the metabolic syndrome?
2006
Insulin signalling and the regulation of glucose and lipid metabolism
2001 StandoutNature
A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients
1989
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance
2003
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Adipose Tissue Metabolites and Insulin Resistance in Nondiabetic Asian Indian Men
2004
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
The metabolic syndrome—a new worldwide definition
2005 Standout
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)–Prevenzione scoring
2006
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
1998
Diabetes, Plasma Insulin, and Cardiovascular Disease
2002
Free Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus
2000
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Are Conventional Risk Factors for Mortality Relevant in Type 2 Diabetes?
1991
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials
2013
A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke
2001
Oral contraceptive use and the risk of Type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women
1992
Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart Disease
1996
Fasting Insulin and Apolipoprotein B Levels and Low-Density Lipoprotein Particle Size as Risk Factors for Ischemic Heart Disease
1998
Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)
2001
Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis
1998 Standout
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
1999
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus: an epidemic in progress
1997
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
1998 Standout
Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth
1993 Standout
Evidence for an independent relationship between insulin resistance and fasting plasma HDL‐cholesterol, triglyceride and insulin concentrations
1992
Platelet-Active Drugs
2001
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus
2004
Relationships of generalized and regional adiposity to insulin sensitivity in men.
1995
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
2005 Standout
Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia.
1996
5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.
1990
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
The Secondary Prevention of Small Subcortical Strokes (SPS3) Study
2011
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Relation of Glycohemoglobin and Adiposity to Atherosclerosis in Youth
1995
The Metabolic Syndrome
2003
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
The practice of carotid endarterectomy in a large metropolitan area.
1984
Relative Contribution of Insulin and Its Precursors to Fibrinogen and PAI-1 in a Large Population With Different States of Glucose Tolerance
1999
A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia.
2000
Free Fatty Acids Are Independently Associated with All-Cause and Cardiovascular Mortality in Subjects with Coronary Artery Disease
2006
Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease Mortality
1997
Diabetes and atherosclerosis: An epidemiologic view
1987
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
1987
Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk
2004
European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
1996
A meta-analysis of randomized controlled trials
2019 Standout
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies
1998
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Predictors of Progression From Impaired Glucose Tolerance to NIDDM: An Analysis of Six Prospective Studies
1997
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]
2004
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Relationships of Abdominal Obesity and Hyperinsulinemia to Angiographically Assessed Coronary Artery Disease in Men With Known Mutations in the LDL Receptor Gene
1998
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
2010
Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase
2004 StandoutScience
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program.
1994
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
2010 Standout
Carotid Endarterectomy and Prevention of Cerebral Ischemia in Symptomatic Carotid Stenosis
1991
Hyperinsulinemia Predicts Coronary Heart Disease Risk in Healthy Middle-aged Men
1998
Risk–Benefit Profile of Long-Term Dual- Versus Single-Antiplatelet Therapy Among Patients With Ischemic Stroke
2013
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Persistent Elevation of Plasma Insulin Levels Is Associated With Increased Cardiovascular Risk in Children and Young Adults
1996
Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance
2004
Effect of Low-Dose Oral Contraceptives on Metabolic Risk Factors in African-American Women
2008
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus
1987
Supplement to the Guidelines for the Management of Transient Ischemic Attacks
1999
Complexity and contradiction in clinical trial research
1987
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction
1999 Standout
Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia.
1993
Adiposity, Type 2 Diabetes, and Alzheimer's Disease
2009
Works of N Thibult being referenced
Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up
1991
Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes
1989
Body fat distribution and coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes mellitus: the Paris Prospective Study, 15-year follow-up
1992
Macronutrient energy intake and adiposity in non obese prepubertal children aged 5–11 y (the Fleurbaix Laventie Ville Santé Study)
2000
Effects of oral contraceptives on carbohydrate and lipid metabolisms in a healthy population: The Telecom Study
1990
The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study
1997
Oral contraceptives, insulin resistance and ischemic vascular disease
1990
High Plasma Nonesterified Fatty Acids Are Predictive of Cancer Mortality but Not of Coronary Heart Disease Mortality: Results from the Paris Prospective Study
2001
Reproducibility of the Diagnosis of Diabetes Over a 30-Month Follow-Up
2001
Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later.
1985
"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.
1983
[Diabetes, hyperglycemia, hyperinsulinemia and risk of cardiovascular mortality. Findings of the Paris Prospective Survey, 10 years later].
1985
Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris Prospective Study.
1992
Risk Factors for NIDDM in White Population: Paris Prospective Study
1991